February 7, 2018 / 12:14 PM / 12 days ago

Aurobindo Pharma Q3 profit up about 3 pct, misses estimates

Feb 7 (Reuters) - Aurobindo Pharma Ltd, India’s third largest drugmaker by revenue, posted an about 3 percent rise in quarterly profit on Wednesday, but missed analysts’ estimates.

Profit was 5.95 billion rupees ($92.6 million) in the third quarter ended Dec. 31, compared with 5.79 billion rupees a year earlier, the Hyderabad-headquartered drugmaker said. bit.ly/2FSPsfo

Analysts on average had expected a profit of 6.71 billion rupees, Thomson Reuters data showed.

Total revenue from operations rose 11 percent to 43.36 billion rupees.

$1 = 64.2600 Indian rupees Reporting by Jessica Kuruthukulangara and Aby Jose Koilparambil in Bengaluru; Editing by Amrutha Gayathri

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below